CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Tumaini Mobile Phone Gamebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03054051
NCT03054051N/ACompleted
CompareCT.gov

A Mobile Phone Game to Prevent HIV Among Young Africans

Emory University·interventional·Posted Feb 15, 2017·Updated Oct 17, 2019

In Brief

A clinical study evaluating Tumaini Mobile Phone Game for HIV/AIDS. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This project will test the feasibility of an electronic game to prevent HIV among African preadolescents, delivered via inexpensive Android smart phones. In order to collect feasibility data for a future randomized controlled trial, this study involves the pilot-testing of the intervention with a sample of young people in Nyanza region, Kenya, where 11.4% of young women ages 15-24 are HIV-infected. This feasibility study will be carried out with the Kenya Medical Research Institute (KEMRI).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV/AIDS
CountriesKenya
CollaboratorsNational Institute of Mental Health (NIMH), Kenya Medical Research Institute

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 15, 2017
Enrollment StartMar 20, 2017
Primary CompletionJun 19, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.4 years ago

Interventions

Tumaini Mobile Phone Gamebehavioral

Tumaini is a scenario-based role-playing game application, optimized for use on low-cost Android smartphones. Participants will be invited to play the game for at least ten hours over a period of three weeks. The game is designed to: educate players about sexual health and HIV/AIDS; build risk-reduction skills and related self-efficacy for prevention of HIV/STIs and unintended pregnancy; challenge HIV stigma and harmful gender norms; and promote parent-child dialogue.